These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33347636)

  • 1. Benzodiazepines: Thinking outside the black box.
    Pergolizzi JV; LeQuang JA; Raffa RB
    J Clin Pharm Ther; 2021 Jun; 46(3):554-559. PubMed ID: 33347636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
    Cowart K; Worley M; Rouby NE; Sando K
    Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in Australian Early-Career General Practitioners' Benzodiazepine Prescribing: a Longitudinal Analysis.
    Magin P; Tapley A; Dunlop AJ; Davey A; van Driel M; Holliday E; Morgan S; Henderson K; Ball J; Catzikiris N; Mulquiney K; Spike N; Kerr R; Holliday S
    J Gen Intern Med; 2018 Oct; 33(10):1676-1684. PubMed ID: 30039495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Value of the Black Box Warning in Dermatology.
    Winterfield L; Vleugels RA; Park KK
    J Drugs Dermatol; 2015 Jul; 14(7):660-6. PubMed ID: 26151780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provider Patient-Sharing Networks and Multiple-Provider Prescribing of Benzodiazepines.
    Ong MS; Olson KL; Cami A; Liu C; Tian F; Selvam N; Mandl KD
    J Gen Intern Med; 2016 Feb; 31(2):164-171. PubMed ID: 26187583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning.
    Zhang VS; Olfson M; King M
    JAMA Psychiatry; 2019 Nov; 76(11):1208-1210. PubMed ID: 31532463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
    Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of safety warnings on ESA prescribing among dialysis patients using an interrupted time series.
    Thamer M; Zhang Y; Lai D; Kshirsagar O; Cotter D
    BMC Nephrol; 2013 Aug; 14():172. PubMed ID: 23927675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient benzodiazepine utilization in Croatia: drug use or misuse.
    Delaš Aždajić M; Likić R; Aždajić S; Šitum M; Lovrić I; Štimac Grbić D
    Int J Clin Pharm; 2019 Dec; 41(6):1526-1535. PubMed ID: 31595447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences.
    Cadogan CA; Ryder SA
    Int J Pharm Pract; 2015 Dec; 23(6):415-22. PubMed ID: 25756294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepine dependence and its treatment with low dose flumazenil.
    Hood SD; Norman A; Hince DA; Melichar JK; Hulse GK
    Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bringing greater transparency to "black box" warnings.
    Buckley NA; Rossi S
    Clin Toxicol (Phila); 2011 Jul; 49(6):448-51. PubMed ID: 21824055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stronger Boxed Warning for Benzodiazepines.
    Aschenbrenner DS
    Am J Nurs; 2021 Mar; 121(3):22-23. PubMed ID: 33625005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation among states in prescribing of opioid pain relievers and benzodiazepines--United States, 2012.
    Paulozzi LJ; Mack KA; Hockenberry JM
    J Safety Res; 2014 Dec; 51():125-9. PubMed ID: 25453186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety Withdrawals.
    Schick A; Miller KL; Lanthier M; Dal Pan G; Nardinelli C
    Drug Saf; 2017 Jun; 40(6):497-503. PubMed ID: 28342075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
    Yeh JS; Sarpatwari A; Kesselheim AS
    Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies.
    Markota M; Rummans TA; Bostwick JM; Lapid MI
    Mayo Clin Proc; 2016 Nov; 91(11):1632-1639. PubMed ID: 27814838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected].
    Davies J; Rae TC; Montagu L
    Br J Gen Pract; 2017 Sep; 67(662):e609-e613. PubMed ID: 28716996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-Label Prescribing of Psychotropic Medication, 2005-2013: An Examination of Potential Influences.
    O'Brien PL; Cummings N; Mark TL
    Psychiatr Serv; 2017 Jun; 68(6):549-558. PubMed ID: 28093058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.